Westside Investment Management, Inc.
Position in RDY — Dr Reddys Laboratories Ltd
CIK 1538383
SANTA MONICA, CA
Position in RDY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$66,581
+$2,180 QoQ
Shares Held
4,595
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#183
of 238 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Westside Investment Management, Inc. holds $25,431,955 across 11 Drug Manufacturers - Specialty & Generic names. RDY ranks #4 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ETON |
Eton Pharmaceuticals, Inc.
|
431,160 | $15,607,992 | |
| 2 | HROW |
Harrow, Inc.
|
224,051 | $9,515,445 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
5,000 | $169,400 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
This page
|
4,595 | $66,581 | |
| 5 | VTRS |
Viatris Inc
|
2,130 | $33,823 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,500 | $15,000 | |
| 7 | HLN |
Haleon plc
|
818 | $7,631 | |
| 8 | CRON |
Cronos Group Inc.
|
2,600 | $7,228 |
All Filings in RDY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,581 | 4,595 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $64,401 | 4,650 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $65,285 | 4,650 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $64,238 | 4,595 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $35,455 | 2,359 | Shares | Sole | 2025-08-05 | |
| No filing history on record for this holder in this stock. | ||||||